Physician profile
Hilda M Brito
NPI 1912063777
$1,782.07
in general payments reported to CMS, 2019-2025
23 companies · $180 in 2025
The $180 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $121 · 2020: $199 · 2021: $320 · 2022: $228 · 2023: $315 · 2024: $419 · 2025: $180.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $915.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $914.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $679.03 | 2020-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Exact Sciences Corporation | $235.36 | 2023-2025 | Cologuard Collection Kit |
| Astrazeneca Pharmaceuticals LP | $187.13 | 2023-2025 | Farxiga |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $183.46 | 2019-2024 | Xifaxan |
| Novo Nordisk INC | $79.63 | 2020-2025 | |
| Amarin Pharma, INC. | $75.72 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $58.29 | 2020-2021 | |
| Phathom Pharmaceuticals, INC. | $42.76 | 2024 | Voquezna |
| Kowa Pharmaceuticals America, INC. | $38.99 | 2019-2025 | Zoryve |
| Cranial Technologies, INC | $31.92 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $24.57 | 2022 | |
| Evoke Pharma, INC. | $19.99 | 2024 | |
| Xeris Pharmaceuticals, INC. | $19.83 | 2021 | |
| Hologic Sales and Service, LLC | $18.99 | 2019 | |
| Phadia US INC. | $18.79 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shield Therapeutics INC | $18.41 | 2022 | |
| Novartis Pharmaceuticals Corporation | $18.00 | 2021 | |
| Nestle Healthcare Nutrition INC. | $17.78 | 2020 | |
| Lilly USA, LLC | $13.42 | 2024 | Mounjaro, Zepbound |
4 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hilda Brito listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.